Healthcare - Genomics & Precision Medicine
Companies in gene therapy, genetic testing, and personalized medicine platforms
Gene Therapy & Gene Editing60
RNA Therapeutics10
Genetic Testing & Diagnostics23
Precision Medicine Platforms49
| Ticker | Company | Sub-Theme | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|---|
 AZN | AstraZeneca PLC | Precision Medicine Platforms | $289.5b | $181.94 | -1.6% | 1.4M |
 TMO | Thermo Fisher Scientific, Inc. | Precision Medicine Platforms | $174.7b | $441.60 | -1.5% | 2.0M |
 DHR | Danaher Corporation | Precision Medicine Platforms | $126.7b | $161.34 | -1.9% | 4.1M |
 VRTX | Vertex Pharmaceuticals Inc | Gene Therapy & Gene Editing | $109.4b | $436.94 | -3.0% | 1.3M |
 REGN | Regeneron Pharmaceuticals Inc | Gene Therapy & Gene Editing | $76.7b | $698.18 | -2.1% | 728.2K |
 ALNY | Alnylam Pharmaceuticals, Inc. | RNA Therapeutics | $40.3b | $286.92 | -2.2% | 1.1M |
 WAT | Waters Corp | Precision Medicine Platforms | $29.5b | $329.22 | -1.2% | 856.3K |
 INSM | Insmed, Inc. | Gene Therapy & Gene Editing | $29.1b | $109.21 | -5.5% | 3.7M |
 NTRA | Natera, Inc. Common Stock | Genetic Testing & Diagnostics | $28.6b | $186.34 | -5.4% | 2.2M |
 LH | Labcorp Holdings Inc. | Genetic Testing & Diagnostics | $21.3b | $250.40 | -1.4% | 568.7K |
 ILMN | Illumina Inc | Genetic Testing & Diagnostics | $19.3b | $142.57 | -0.5% | 1.8M |
 BBIO | BridgeBio Pharma, Inc. Common Stock | Precision Medicine Platforms | $13.5b | $66.13 | -5.1% | 2.7M |
 IONS | Ionis Pharmaceuticals, Inc. Common Stock | RNA Therapeutics | $11.9b | $74.25 | -1.9% | 2.1M |
 GH | Guardant Health, Inc. Common Stock | Precision Medicine Platforms | $10.9b | $94.88 | -3.8% | 1.8M |
 BMRN | BioMarin Pharmaceuticals Inc | Gene Therapy & Gene Editing | $10.3b | $51.82 | -2.7% | 2.1M |
 ARWR | Arrowhead Research Corporation | RNA Therapeutics | $9.8b | $76.67 | -3.8% | 1.7M |
 RVTY | Revvity, Inc. | Precision Medicine Platforms | $9.5b | $94.25 | -2.2% | 1.2M |
 TEM | Tempus AI, Inc. Class A Common Stock | Precision Medicine Platforms | $9.2b | $43.89 | -3.5% | 5.9M |
 PRAX | Praxis Precision Medicines, Inc. Common Stock | Precision Medicine Platforms | $9.0b | $341.35 | -1.2% | 343.7K |
 TECH | Bio-Techne Corp. | Precision Medicine Platforms | $8.4b | $43.30 | -3.2% | 5.2M |
 NUVL | Nuvalent, Inc. Class A Common Stock | Precision Medicine Platforms | $8.0b | $102.33 | -2.0% | 798.5K |
 KRYS | Krystal Biotech, Inc. Common Stock | Gene Therapy & Gene Editing | $7.9b | $306.52 | -3.1% | 316.5K |
 QGEN | QIAGEN N.V. | Genetic Testing & Diagnostics | $7.0b | $32.98 | -0.9% | 1.8M |
 KYMR | Kymera Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $6.8b | $82.23 | -2.7% | 468.3K |
 LNTH | Lantheus Holdings, Inc | Precision Medicine Platforms | $5.4b | $93.89 | -2.9% | 926.9K |
 CAI | Caris Life Sciences, Inc. Common Stock | Precision Medicine Platforms | $5.2b | $14.56 | -4.5% | 4.7M |
 CRSP | CRISPR Therapeutics AG | Gene Therapy & Gene Editing | $5.0b | $48.42 | -4.0% | 2.0M |
 FOLD | Amicus Therapeutics, Inc | Gene Therapy & Gene Editing | $4.5b | $14.49 | +0.0% | 3.5M |
 TWST | Twist Bioscience Corporation Common Stock | Precision Medicine Platforms | $3.6b | $49.18 | -7.1% | 2.6M |
 BLLN | BillionToOne, Inc. Class A Common Stock | Genetic Testing & Diagnostics | $3.6b | $82.54 | -6.1% | 1.1M |
 BEAM | Beam Therapeutics Inc. Common Stock | Gene Therapy & Gene Editing | $3.1b | $27.93 | -5.4% | 2.0M |
 DYN | Dyne Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $3.0b | $17.30 | -5.4% | 1.2M |
 TXG | 10x Genomics, Inc. Class A Common Stock | Genetic Testing & Diagnostics | $2.8b | $21.18 | -1.6% | 2.7M |
 VCYT | Veracyte, Inc. | Genetic Testing & Diagnostics | $2.7b | $38.48 | -1.1% | 944.8K |
 IDYA | IDEAYA Biosciences, Inc. Common Stock | Precision Medicine Platforms | $2.6b | $28.19 | -2.3% | 867.8K |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | Precision Medicine Platforms | $2.2b | $12.82 | -2.7% | 1.6M |
 SRPT | Sarepta Therapeutics,, Inc. Common Stock | Gene Therapy & Gene Editing | $2.2b | $17.54 | -6.1% | 4.6M |
 WGS | GeneDx Holdings Corp. Class A Common Stock | Precision Medicine PlatformsGenetic Testing & Diagnostics | $1.9b | $40.73 | +4.8% | 1.6M |
 VCEL | Vericel Corporation | Gene Therapy & Gene Editing | $1.8b | $33.03 | -0.3% | 449.0K |
 TSHA | Taysha Gene Therapies, Inc. Common Stock | Gene Therapy & Gene Editing | $1.8b | $5.97 | -5.2% | 3.3M |
 NTLA | Intellia Therapeutics, Inc | Gene Therapy & Gene Editing | $1.6b | $13.65 | +4.3% | 14.8M |
 WVE | Wave Life Sciences Ltd. Ordinary Shares | RNA Therapeutics | $1.4b | $6.77 | -1.9% | 4.2M |
 MAZE | Maze Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $1.4b | $25.59 | -3.2% | 411.8K |
 PGEN | Precigen, Inc. Common Stock | Gene Therapy & Gene Editing | $1.4b | $4.42 | -4.0% | 3.6M |
 NEO | NeoGenomics, Inc. | Genetic Testing & Diagnostics | $1.2b | $8.24 | -1.4% | 1.1M |
 QURE | uniQure N.V. | Gene Therapy & Gene Editing | $1.1b | $27.02 | -2.6% | 1.5M |
 CDNA | CareDx, Inc. | Precision Medicine PlatformsGenetic Testing & Diagnostics | $1.1b | $19.95 | -2.6% | 637.6K |
 AZTA | Azenta, Inc. | Genetic Testing & Diagnostics | $1.1b | $16.02 | -4.6% | 1.4M |
 PCRX | Pacira BioSciences, Inc. Common Stock | Gene Therapy & Gene Editing | $1.0b | $22.62 | -3.9% | 449.8K |
 BLFS | BioLife Solutions Inc. | Gene Therapy & Gene Editing | $1.0b | $20.73 | -1.5% | 375.0K |